Citation:Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M 2004

Citation

Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 2004 Oct 1;22(19):3860-7 Available from: http://www.ncbi.nlm.nih.gov/pubmed/15326194.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M 2004	What is the role of chemotherapy after surgery in the treatment of operable stage I NSCLC?	Associate Professor Christos Karapetis	completed
Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M 2004 2	What is the role of chemotherapy after surgery in the treatment of operable stage II NSCLC?	Dr Shawgi Sukumaran	completed
Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M 2004 3	What is the clinical benefit of adjuvant chemotherapy for patients with stage III operable NSCLC?	Professor Michael Brown MBBS PhD FRACP FRCPA	completed
Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M 2004 4	What is the optimal systemic therapy for stage IV inoperable NSCLC?	Assoc. Prof. Nick Pavlakis	completed
Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M 2004 5	Is carboplatin based chemotherapy as effective as cisplatin based chemotherapy for treatment of stage IV inoperable NSCLC?	Assoc. Prof. Nick Pavlakis	completed
Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M 2004 6	Is monotherapy with new third generation (3G) agents as effective as platinum combination therapy for treatment of stage IV inoperable NSCLC?	Assoc. Prof. Nick Pavlakis	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What is the role of chemotherapy after surgery in the treatment of operable stage I NSCLC?|]] (compare critical appraisals)
• [[Clinical question:What is the role of chemotherapy after surgery in the treatment of operable stage II NSCLC?|]] (compare critical appraisals)
• [[Clinical question:What is the clinical benefit of adjuvant chemotherapy for patients with stage III operable NSCLC?|]] (compare critical appraisals)
• [[Clinical question:What is the optimal systemic therapy for stage IV inoperable NSCLC?|]] (compare critical appraisals)
• [[Clinical question:Is carboplatin based chemotherapy as effective as cisplatin based chemotherapy for treatment of stage IV inoperable NSCLC?|]] (compare critical appraisals)
• [[Clinical question:Is monotherapy with new third generation (3G) agents as effective as platinum combination therapy for treatment of stage IV inoperable NSCLC?|]] (compare critical appraisals)

Cited by

1. Is carboplatin based chemotherapy as effective as cisplatin based chemotherapy for treatment of stage IV inoperable NSCLC?
2. Is monotherapy with new third generation (3G) agents as effective as platinum combination therapy for treatment of stage IV inoperable NSCLC?
3. What is the optimal systemic therapy for stage IV inoperable NSCLC?